They found that approximately 30% of the FSP1+ cells in the tumour stroma were β-galactosidase and FSP1 double positive, and 12% of the a-SMA+ cells revealed double positivity for a-SMA and β-galactosidase [25]. The gene discussed is SMN1; the disease is neoplasm.